XML 13 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Total
Common Stock
Additional Paid in Capital
Accumulated Deficit
Beginning Balances at Dec. 31, 2022 $ 48,339,114 $ 111,091 $ 49,029,712 $ (801,689)
Beginning Balance, shares at Dec. 31, 2022   11,109,077    
Restricted stock grants issued   $ 380 (380)  
Restricted stock grants issued, Shares   37,976    
Restricted stock grant forfeiture   $ (32) 32  
Restricted stock grant forfeitures, shares   (3,145)    
Stock-based compensation 37,787   37,787  
Net income 992,541     992,541
Dividends (805,228)     (805,228)
Ending Balance at Mar. 31, 2023 48,564,214 $ 111,439 49,067,151 (614,376)
Ending Balance, shares at Mar. 31, 2023   11,143,908    
Beginning Balances at Dec. 31, 2022 48,339,114 $ 111,091 49,029,712 (801,689)
Beginning Balance, shares at Dec. 31, 2022   11,109,077    
Net income 1,570,611      
Ending Balance at Jun. 30, 2023 48,378,272 $ 111,439 49,111,072 (844,239)
Ending Balance, shares at Jun. 30, 2023   11,143,908    
Beginning Balances at Mar. 31, 2023 48,564,214 $ 111,439 49,067,151 (614,376)
Beginning Balance, shares at Mar. 31, 2023   11,143,908    
Stock-based compensation 43,921   43,921  
Net income 578,070     578,070
Dividends (807,933)     (807,933)
Ending Balance at Jun. 30, 2023 48,378,272 $ 111,439 49,111,072 (844,239)
Ending Balance, shares at Jun. 30, 2023   11,143,908    
Beginning Balances at Dec. 31, 2023 $ 48,246,027 $ 111,535 49,229,020 (1,094,528)
Beginning Balance, shares at Dec. 31, 2023 11,153,513 11,153,513    
Restricted stock grants issued   $ 1,144 (1,144)  
Restricted stock grants issued, Shares   114,378    
Restricted stock grant forfeiture   $ (8) 8  
Restricted stock grant forfeitures, shares   (843)    
Stock-based compensation $ 71,004   71,004  
Net income 266,150     266,150
Dividends (808,568)     (808,568)
Ending Balance at Mar. 31, 2024 47,774,613 $ 112,671 49,298,888 (1,636,946)
Ending Balance, shares at Mar. 31, 2024   11,267,048    
Beginning Balances at Dec. 31, 2023 $ 48,246,027 $ 111,535 49,229,020 (1,094,528)
Beginning Balance, shares at Dec. 31, 2023 11,153,513 11,153,513    
Net income $ 857,680      
Ending Balance at Jun. 30, 2024 $ 47,622,227 $ 112,668 49,371,816 (1,862,257)
Ending Balance, shares at Jun. 30, 2024 11,266,761 11,266,761    
Beginning Balances at Mar. 31, 2024 $ 47,774,613 $ 112,671 49,298,888 (1,636,946)
Beginning Balance, shares at Mar. 31, 2024   11,267,048    
Restricted stock grants issued   $ 4 (4)  
Restricted stock grants issued, Shares   400    
Restricted stock grant forfeiture   $ (7) 7  
Restricted stock grant forfeitures, shares   (687)    
Stock-based compensation 72,925   72,925  
Net income 591,530     591,530
Dividends (816,841)     (816,841)
Ending Balance at Jun. 30, 2024 $ 47,622,227 $ 112,668 $ 49,371,816 $ (1,862,257)
Ending Balance, shares at Jun. 30, 2024 11,266,761 11,266,761